- Home
- ATNM vs PRTS Comparison
ATNM vs PRTS Comparison
Compare ATNM & PRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- PRTS
- Stock Information
- Founded
- ATNM 2000
- PRTS 1995
- Country
- ATNM United States
- PRTS United States
- Employees
- ATNM N/A
- PRTS N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- PRTS Auto & Home Supply Stores
- Sector
- ATNM Health Care
- PRTS Consumer Discretionary
- Exchange
- ATNM Nasdaq
- PRTS Nasdaq
- Market Cap
- ATNM 51.5M
- PRTS 47.8M
- IPO Year
- ATNM N/A
- PRTS 2007
- Fundamental
- Price
- ATNM $1.54
- PRTS $0.88
- Analyst Decision
- ATNM Strong Buy
- PRTS Buy
- Analyst Count
- ATNM 3
- PRTS 2
- Target Price
- ATNM $4.67
- PRTS $1.40
- AVG Volume (30 Days)
- ATNM 229.8K
- PRTS 708.7K
- Earning Date
- ATNM 05-09-2025
- PRTS 05-13-2025
- Dividend Yield
- ATNM N/A
- PRTS N/A
- EPS Growth
- ATNM N/A
- PRTS N/A
- EPS
- ATNM N/A
- PRTS N/A
- Revenue
- ATNM N/A
- PRTS $569,935,000.00
- Revenue This Year
- ATNM N/A
- PRTS $1.73
- Revenue Next Year
- ATNM N/A
- PRTS $5.48
- P/E Ratio
- ATNM N/A
- PRTS N/A
- Revenue Growth
- ATNM N/A
- PRTS N/A
- 52 Week Low
- ATNM $1.03
- PRTS $0.68
- 52 Week High
- ATNM $8.64
- PRTS $1.45
- Technical
- Relative Strength Index (RSI)
- ATNM 49.81
- PRTS 51.24
- Support Level
- ATNM $1.56
- PRTS $0.80
- Resistance Level
- ATNM $1.69
- PRTS $0.94
- Average True Range (ATR)
- ATNM 0.11
- PRTS 0.06
- MACD
- ATNM -0.01
- PRTS 0.01
- Stochastic Oscillator
- ATNM 32.18
- PRTS 67.32
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.